Cargando…

Inflammatory bowel disease: towards a personalized medicine

The management of inflammatory bowel disease (IBD) has been transformed over the last two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently, alternative drugs have been approved, directed at leukocyte-trafficking molecules (vedolizumab) or other inflammatory cytokines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flamant, Mathurin, Roblin, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784543/ https://www.ncbi.nlm.nih.gov/pubmed/29383027 http://dx.doi.org/10.1177/1756283X17745029

Ejemplares similares

Use of imaging modalities for decision-making in inflammatory bowel disease
por: Nancey, Stéphane, et al.
Publicado: (2023)

Golimumab for the treatment of ulcerative colitis
por: Flamant, Mathurin, et al.
Publicado: (2017)

Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions
por: Ward, Mark G., et al.
Publicado: (2018)

Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine
por: Kumar, Manoj, et al.
Publicado: (2019)

Personalized Nutrition for Inflammatory Bowel Disease
por: Collins, Colm B, et al.
Publicado: (2020)

Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)
por: Jentzer, Alexandre, et al.
Publicado: (2020)

Precision Medicine in Inflammatory Bowel Disease
por: Annese, Vito, et al.
Publicado: (2023)

Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
por: Cassandra, Rayer, et al.
Publicado: (2022)

Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
por: Rayer, Cassandra, et al.
Publicado: (2023)

Metabolomics facilitate the personalized management in inflammatory bowel disease
por: Chen, Rirong, et al.
Publicado: (2021)

Towards personalized medicine in Ménière’s disease
por: Lopez-Escamez, Jose Antonio, et al.
Publicado: (2018)

Management of inflammatory bowel disease in older persons: evolving paradigms
por: Kedia, Saurabh, et al.
Publicado: (2018)

Patient-derived organoids for therapy personalization in inflammatory bowel diseases
por: Lucafò, Marianna, et al.
Publicado: (2022)

Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine
por: Gehin, Johanna Elin, et al.
Publicado: (2022)

Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease
por: Roblin, Xavier, et al.
Publicado: (2023)

Organoid-based regenerative medicine for inflammatory bowel disease
por: Okamoto, Ryuichi, et al.
Publicado: (2020)

Precision Nutrition Initiative: Toward Personalized Diet Recommendations for Patients With Inflammatory Bowel Diseases
por: Hurtado-Lorenzo, Andrés, et al.
Publicado: (2020)

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
por: Salvador-Martín, Sara, et al.
Publicado: (2021)

Precision medicine in inflammatory bowel disease: concept, progress and challenges
por: Borg-Bartolo, Simon P., et al.
Publicado: (2020)

Inflammatory Bowel Disease: A Personalized Approach
por: Konidari, Anastasia, et al.
Publicado: (2021)

Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future?
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023)

Systematic Review of Recent Lipidomics Approaches Toward Inflammatory Bowel Disease
por: Lee, Eun Goo, et al.
Publicado: (2021)

Precision Medicine in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2021)

Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets
por: Bourgonje, Arno R., et al.
Publicado: (2023)

Systems biology in inflammatory bowel diseases: on the way to precision medicine
por: Dovrolis, Nikolas, et al.
Publicado: (2019)

Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies
por: Yamamoto-Furusho, Jesús K
Publicado: (2017)

Personalized Dietary Regimens for Inflammatory Bowel Disease: Current Knowledge and Future Perspectives
por: Wellens, Judith, et al.
Publicado: (2023)

Precision medicine and drug optimization in adult inflammatory bowel disease patients
por: Vieujean, Sophie, et al.
Publicado: (2023)

Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste
por: Gower-Rousseau, Corinne, et al.
Publicado: (2021)

Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond
por: Di Paolo, Antonello, et al.
Publicado: (2021)

Pharmacogenomics of sickle cell disease: steps toward personalized medicine
por: Husain, Marium, et al.
Publicado: (2017)

Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine
por: Giachero, Federica, et al.
Publicado: (2021)

The Bowel Microbiota and Inflammatory Bowel Diseases
por: Tannock, Gerald W.
Publicado: (2010)

Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
por: Gao, Caifang, et al.
Publicado: (2019)

Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment
por: Yuan, Shuo, et al.
Publicado: (2022)

Alexithymia and personality traits of patients with inflammatory bowel disease
por: La Barbera, D., et al.
Publicado: (2017)

Vagus Nerve Stimulation: A Personalized Therapeutic Approach for Crohn’s and Other Inflammatory Bowel Diseases
por: Cirillo, Giovanni, et al.
Publicado: (2022)

Towards Structural Systems Pharmacology to Study Complex Diseases and Personalized Medicine
por: Xie, Lei, et al.
Publicado: (2014)

Pharmacogenomics in osteoporosis: Steps toward personalized medicine
por: Greene, Robert, et al.
Publicado: (2009)

Towards Personalized Medicine in Psoriasis: Current Progress
por: Camela, Elisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_13gcf0npr2hkbghlt25omlki2j